Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Far EasTone Telecommunications operates Taiwan’s third-largest telecom network. In addition to core telecom services, it has developed commercialized digital healthcare solutions including a "5G remote diagnosis and treatment platform" used in partnership with hospitals to deliver telemedicine. Its AI-powered voice model can identify early symptoms of laryngeal cancer with an accuracy rate of about 80%, supporting rural healthcare access. The company collaborates closely with Intel, Jieluo Biotechnology, and major hospitals on these initiatives. No clinical trial results typical of biotech/pharma companies are available.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Far EasTone Telecommunications.